Form 4: Alignment Healthcare Executive Hakan Kardes Sells Shares

Sentiment:

SEC Form 4 Filing


Hakan Kardes, Chief Experience Officer of Alignment Healthcare, sold a portion of his holdings in two transactions on November 1st and 4th, 2024.

Summary

  • Hakan Kardes, the Chief Experience Officer of Alignment Healthcare, sold shares of the company's common stock.
  • On November 1, 2024, he sold 4,500 shares at a weighted average price of $12.9807.
  • On November 4, 2024, he sold 20,500 shares at a weighted average price of $13.0585.
  • These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2024.
  • Following these sales, Kardes directly owns 355,444 shares of Alignment Healthcare.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating insider trading activity. The sentiment is neutral as it simply reports transactions without expressing any opinion on the company's performance or future prospects.

Industry Context

Insider selling is a common occurrence and can be for various reasons, including personal financial planning. It's important to consider the context of the sales, such as the existence of a pre-arranged trading plan, to understand the potential implications.

Stakeholder Impact

  • The sale of shares by a company executive could be perceived negatively by some investors, potentially leading to a slight decrease in stock price, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates

DateDescription
03/14/2024Date of Rule 10b5-1 plan adoption
11/01/2024Sale of 4,500 shares of common stock
11/04/2024Sale of 20,500 shares of common stock
11/05/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.